Please use this identifier to cite or link to this item:
|Title:||Effect of thiol functionalization on the hemo-compatibility of PLGA nanoparticles|
|Authors:||Thasneem, Y. M.|
Sharma, Chandra P.
|Publisher:||JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A|
|Citation:||JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A. 99A; 4; 607-617|
|Abstract:||In this study, an attempt was made to reduce the interaction of poly(D, L-lactic acid/glycolic acid) (PLGA) nanoparticles with the opsonins and phagocytic cells upon functionalization with thiol groups. Terminal carboxylic groups in PLGA were conjugated to the amino group of cysteine and nanoparticles were prepared by solvent evaporation technique. Detailed in vitro investigations were performed on PLGA and cysteine modified PLGA (Cys-PLGA) nanoparticles to asses their blood compatibility. The effect of these nanoparticles on the release of proinflammatory cytokines (IL-1 beta, IL-6, and TNF-alpha) from human macrophage cells were evaluated. Thiolation was confirmed by fourier transform infrared spectroscopy and Ellman's assay; both PLGA and modified nanoparticles had average size in the range of 250 nm. Thiolation was an effective strategy in reducing the protein adsorption, complement activation, and platelet activation of PLGA nanoparticles. PLGA and modified PLGA nanoparticles were compatible with the blood cells and no hemolytic effect was detected. Particles were noncytotoxic on L929 cells and release of proinflammatory cytokines from macrophage cells was rather unaffected with the modification strategy. From these studies, it seems that thiolation of particulate delivery system is an interesting approach in manipulating the blood-particle interactions and appears to be an effective candidate for injectable drug delivery applications. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 99A: 607-617, 2011.|
|Appears in Collections:||Journal Articles|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.